Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mediascan59on Feb 21, 2010 10:35pm
475 Views
Post# 16805105

Weekend TA

Weekend TA

Ok, I just finished and extensive TA report and suddenly my report just disappeared.

So...In short, I think we will be drifting in this area for a while still.

Low volumes will allow manipulation both ways and not give a true direction of the stock.
At this point, the stock is a hold with possible opportunities to add or buy if the stock is manipulated downward.
With these volumes, it will most likely be hard to pick up very much stock.
It will take news to kick start this stock again, so patience is the word for now.
Happy Trading all
Mediascan

Bullboard Posts